Non-Exclusive License Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Ubiquity, Inc. – Non-Exclusive License Agreement (May 11th, 2016)

This AGREEMENT is effective as of May 5, 2016. By and between Ubiquity Incorporated, a corporation organized and existing under the laws of the State of Nevada, whose principal place of business is located at 9801 Research Drive, Irvine, California 9218, hereinafter referred to as ("Licensor"), and Dash Radio, a corporation organized and existing under the laws of the State Delaware, whose principal place of business is located at 1952 North Cahuenga Blvd. Los Angeles, CA 90068, hereinafter referred to as ("Licensee"). Together herein referred to as the (Parties")

AveXis, Inc. – Confidential Treatment Requested Non-Exclusive License Agreement (January 15th, 2016)

This Non-Exclusive License Agreement (this "Agreement") is made and entered into as of this 29th day of May, 2015 (the "Effective Date"), by and between ASKLEPIOS BIOPHARMACEUTICAL, INC., a North Carolina corporation with an address at 45 North Chatham Parkway, Chapel Hill, NC 27517 ("AskBio"), and AVEXIS, INC., a Delaware corporation with an address at 4925 Greenville Avenue, Suite 604, Dallas, Texas 75206 ("AveXis"). AskBio and AveXis may be referred to herein individually as a "Party" and collectively as the "Parties."

Texas Rare Earth Resources Corp. – Amendment No. 1 to Non-Exclusive License Agreement From (November 30th, 2015)

This amendment number one ("Amendment No. 1") to the Non-Exclusive License Agreement from Reetech, LLC to Texas Rare Earth Resources Corp. ("Non-Exclusive License Agreement") is hereby entered into and agreed to by Reetech, LLC, a limited liability company having its principal office at 4306 Wallace Road, Lakeland, Florida 33812 ("Reetech"), and Texas Rare Earth Resources Corp., a company incorporated in the State of Delaware, and domiciled at 539 El Paso St., Sierra Blanca, Texas 79851 ("TRER"), effective on this 27th day of August, 2015 (the "Effective Date").

Applied Genetic Technologies Corp – Second Amendment to Non-Exclusive License Agreement (Converted to Exclusive License Agreement) (September 10th, 2015)

This Second Amendment to the Non-Exclusive License Agreement (this "Second Amendment") is made and entered into this 29th day of June, 2015 (the "Second Amendment Effective Date") by and between The UAB Research Foundation, an Alabama not-for-profit corporation having a principal place of business at 701 20th St. S., Birmingham, AL 35233 ("UABRF") and Applied Genetic Technologies Corporation, a corporation existing and organized under the laws of the State of Delaware and having a principal place of business at 11801 Research Drive, Suite D, Alachua, Florida 32615 (the "Licensee"). Each of UABRF and the Licensee are referred to in this Amendment individually as a "Party" and collectively as the "Parties". All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the License Agreement (defined below).

Syncardia Systems Inc – Non-Exclusive License Agreement (August 17th, 2015)

This Non-Exclusive License Agreement (Agreement) is effective this 27th day of July, 2013 (Effective Date), between Medtronic Inc., having an address at 8200 Coral Sea Street N.E., Moundsview, MN 55112 (Medtronic), and SynCardia Systems, Inc., having an address at 1992 Silverlake Road, Tucson, AZ 85713 (SynCardia). Each of Medtronic and SynCardia is referred to herein individually as a Party and together as the Parties.

Ciphergen Biosystems – Non-Exclusive License Agreement (May 12th, 2015)

This Non-Exclusive License Agreement ("Agreement") shall be effective as of March 11, 2015 ("Effective Date") by and between Quest Diagnostics Clinical Laboratories, Inc., a Delaware corporation, as successor-in-interest to Pathway Diagnostics, and its parent company Quest Diagnostics Incorporated, a Delaware corporation having a principal place of business at 3 Giralda Farms, Madison, New Jersey 07940 (together, the "Licensor"), and Vermillion, Inc., a Delaware corporation (formerly known as Ciphergen Biosystems, Inc.) ("Vermillion"), and Aspira Labs, a Delaware corporation and wholly owned subsidiary of Vermillion having a principal place of business at 101 Cooperative Way, Suite 220,Georgetown, TX 78626 (together with Vermillion, "Licensee").

Anterios Inc – Non-Exclusive License Agreement (April 27th, 2015)

This Agreement, effective as of August 13 , 2007 (the Effective Date), is between the University of Massachusetts (University), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus, and, Anterios, Inc. (f/k/a Encapsion, Inc.) (Company), a Delaware corporation with headquarters at 41 West 57th Street (6th floor), New York, New York 10019.

Anterios Inc – A Request for Confidential Treatment Has Been Made With Respect to Portions of the Following Document That Are Marked With [*]. The Redacted Portions Have Been Filed Separately With the SEC. Second Amendment to Non-Exclusive License Agreement (April 27th, 2015)

This second amendment (Second Amendment) to the Non-Exclusive License Agreement effective August 13, 2007 by and between the University of Massachusetts, a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus (University) and Anterios, Inc. a Delaware corporation with an address of 142 West 57th Street (6th floor), New York, New York 10019 (Company) is effective as of August 13, 2010 (the Second Amendment Effective Date).

MultiVir Inc. – Confidential Treatment Requested Confidential Portions of This Document Have Been Redacted and Have Been Separately Filed With the Securities and Exchange Commission Non-Exclusive License Agreement (April 23rd, 2015)

This Non-Exclusive License Agreement (this Agreement), effective as of the date of last signature hereto (the Effective Date), is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, having a place of business at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (Merck) and P53 INC., a corporation organized and existing under the laws of Delaware, having a place of business at 2000 Edwards Street, Houston, TX 77007 (P53).

Anterios Inc – Second Amendment to Non-Exclusive License Agreement (March 31st, 2015)

This second amendment (Second Amendment) to the Non-Exclusive License Agreement effective August 13, 2007 by and between the University of Massachusetts, a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus (University) and Anterios, Inc. a Delaware corporation with an address of 142 West 57th Street (6th floor), New York, New York 10019 (Company) is effective as of August 13, 2010 (the Second Amendment Effective Date).

Anterios Inc – Non-Exclusive License Agreement (March 31st, 2015)

This Agreement, effective as of August 13 , 2007 (the Effective Date), is between the University of Massachusetts (University), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus, and, Anterios, Inc. (f/k/a Encapsion, Inc.) (Company), a Delaware corporation with headquarters at 41 West 57th Street (6th floor), New York, New York 10019.

MultiVir Inc. – Confidential Treatment Requested Confidential Portions of This Document Have Been Redacted and Have Been Separately Filed With the Securities and Exchange Commission Non-Exclusive License Agreement (March 30th, 2015)

This Non-Exclusive License Agreement (this Agreement), effective as of the date of last signature hereto (the Effective Date), is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, having a place of business at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (Merck) and P53 INC., a corporation organized and existing under the laws of Delaware, having a place of business at 2000 Edwards Street, Houston, TX 77007 (P53).

Anterios Inc – Second Amendment to Non-Exclusive License Agreement (January 7th, 2015)

This second amendment (Second Amendment) to the Non-Exclusive License Agreement effective August 13, 2007 by and between the University of Massachusetts, a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus (University) and Anterios, Inc. a Delaware corporation with an address of 142 West 57th Street (6th floor), New York, New York 10019 (Company) is effective as of August 13, 2010 (the Second Amendment Effective Date).

Anterios Inc – Non-Exclusive License Agreement (January 7th, 2015)

This Agreement, effective as of August 13 , 2007 (the Effective Date), is between the University of Massachusetts (University), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus, and, Anterios, Inc. (f/k/a Encapsion, Inc.) (Company), a Delaware corporation with headquarters at 41 West 57th Street (6th floor), New York, New York 10019.

MultiVir Inc. – Confidential Treatment Requested Confidential Portions of This Document Have Been Redacted and Have Been Separately Filed With the Securities and Exchange Commission Non-Exclusive License Agreement (December 22nd, 2014)

This Non-Exclusive License Agreement (this Agreement), effective as of the date of last signature hereto (the Effective Date), is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, having a place of business at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (Merck) and P53 INC., a corporation organized and existing under the laws of Delaware, having a place of business at 2000 Edwards Street, Houston, TX 77007 (P53).

World Energy Solutions – Non-Exclusive License Agreement (December 16th, 2014)

This Non-Exclusive License Agreement (this "Agreement") is made and entered into effective as of December 10, 2014 (the "Effective Date") by and among World Surveillance Group Inc. (hereinafter referred to as "World"), Global Telesat Corp. (hereinafter referred to as "GTC"), a wholly-owned subsidiary of World, Great West Resources, Inc. (hereinafter referred to as "Parent"), and Orbital Satcom Corp., a wholly owned subsidiary of Parent (hereinafter referred to as "Licensee" and, together with GTC, World and Parent, the "Parties").

Sanswire Corp – Non-Exclusive License Agreement Preamble (December 16th, 2014)

This Non-Exclusive License Agreement (this "Agreement") is made and entered into effective as of December 10, 2014 (the "Effective Date") by and among World Surveillance Group Inc. (hereinafter referred to as "World"), Global Telesat Corp. (hereinafter referred to as "GTC"), a wholly-owned subsidiary of World, Great West Resources, Inc. (hereinafter referred to as "Parent"), and Orbital Satcom Corp., a wholly owned subsidiary of Parent (hereinafter referred to as "Licensee" and, together with GTC, World and Parent, the "Parties").

Syncardia Systems Inc – Non-Exclusive License Agreement (December 4th, 2014)

This Non-Exclusive License Agreement (Agreement) is effective this 27th day of July, 2013 (Effective Date), between Medtronic Inc., having an address at 8200 Coral Sea Street N.E., Moundsview, MN 55112 (Medtronic), and SynCardia Systems, Inc., having an address at 1992 Silverlake Road, Tucson, AZ 85713 (SynCardia). Each of Medtronic and SynCardia is referred to herein individually as a Party and together as the Parties.

CONFIDENTIAL NON-EXCLUSIVE LICENSE AGREEMENT [Cabilly Patents] (September 25th, 2014)

This Non-Exclusive License Agreement (Agreement) is effective as of July 10, 2013 (Effective Date) by and between Genentech, Inc., a corporation having its principal place of business at 1 DNA Way, South San Francisco, California 94080 (hereinafter Genentech) and Coherus Biosciences, Inc., a corporation having its principal place of business at 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (hereinafter Coherus).

Medifocus Inc. – NON-EXCLUSIVE LICENSE AGREEMENT (Seller Out-License Agreement) (September 17th, 2014)

This Non-Exclusive License Agreement (this Agreement) dated as of July 24, 2012 (the Effective Date) by and between BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (Licensor) and MEDIFOCUS, INC., a Canadian corporation (Licensee).

Medifocus Inc. – NON-EXCLUSIVE LICENSE AGREEMENT (Buyer Out-License Agreement) (September 17th, 2014)

This Non-Exclusive License Agreement (the Agreement) is made as of July 24, 2012 (the Effective Date) by and between MEDIFOCUS, INC., a Canadian corporation (Licensor) and BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (Licensee).

CONFIDENTIAL NON-EXCLUSIVE LICENSE AGREEMENT [Cabilly Patents] (August 5th, 2014)

This Non-Exclusive License Agreement (Agreement) is effective as of July 10, 2013 (Effective Date) by and between Genentech, Inc., a corporation having its principal place of business at 1 DNA Way, South San Francisco, California 94080 (hereinafter Genentech) and Coherus Biosciences, Inc., a corporation having its principal place of business at 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (hereinafter Coherus).

Applied Genetic Technologies Corp – First Amendment to Non-Exclusive License Agreement (July 11th, 2014)

This First Amendment to the Non-Exclusive License Agreement (this First Amendment) is made and entered into this 28th day of March, 2014 (the First Amendment Effective Date) by and between The UAB Research Foundation, an Alabama not-for-profit corporation having a principal place of business at 701 20th St. S., Birmingham, AL 35233 (UABRF) and Applied Genetic Technologies Corporation, a corporation existing and organized under the laws of the state of California and having a principal place of business at 11801 Research Drive, Suite D, Alachula, Florida 32615 (the Licensee). Each of UABRF and the Licensee are referred to in this Agreement individually as a Party and collectively as the Parties. All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the License Agreement (defined below).

***Text Omitted and Filed Separately With the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 Non-Exclusive License Agreement Between the Regents of the University of California and Sage Therapeutics, Inc. For Allopregnanolone in the Treatment of Status Epilepticus and Post-Partum Depression File No. [ *** ] (July 8th, 2014)

This non-exclusive license agreement (Agreement) is effective this 23rd day of October 2013 (Effective Date), by and between The Regents of the University of California (The Regents), a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200, as represented by its Davis campus, having an address at UC Davis InnovationAccess, 1850 Research Park Drive, Suite 100, Davis, California 95618 and Sage Therapeutics, Inc. (Licensee), a Delaware corporation, having a principal place of business at 215 First Street, Cambridge, Massachusetts 02142. The Regents and Licensee will be referred to herein, on occasion, individually as Party or collectively as Parties.

***Text Omitted and Filed Separately With the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 Non-Exclusive License Agreement Between the Regents of the University of California and Sage Therapeutics, Inc. For Allopregnanolone in the Treatment of Status Epilepticus and Post-Partum Depression File No. [ *** ] (May 30th, 2014)

This non-exclusive license agreement (Agreement) is effective this 23rd day of October 2013 (Effective Date), by and between The Regents of the University of California (The Regents), a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200, as represented by its Davis campus, having an address at UC Davis InnovationAccess, 1850 Research Park Drive, Suite 100, Davis, California 95618 and Sage Therapeutics, Inc. (Licensee), a Delaware corporation, having a principal place of business at 215 First Street, Cambridge, Massachusetts 02142. The Regents and Licensee will be referred to herein, on occasion, individually as Party or collectively as Parties.

Medifocus Inc. – NON-EXCLUSIVE LICENSE AGREEMENT (Buyer Out-License Agreement) (April 2nd, 2014)

This Non-Exclusive License Agreement (the Agreement) is made as of July 24, 2012 (the Effective Date) by and between MEDIFOCUS, INC., a Canadian corporation (Licensor) and BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (Licensee).

Medifocus Inc. – NON-EXCLUSIVE LICENSE AGREEMENT (Seller Out-License Agreement) (April 2nd, 2014)

This Non-Exclusive License Agreement (this Agreement) dated as of July 24, 2012 (the Effective Date) by and between BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (Licensor) and MEDIFOCUS, INC., a Canadian corporation (Licensee).

uniQure B.V. – Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. NON-EXCLUSIVE LICENSE AGREEMENT (January 31st, 2014)

This License Agreement (the Agreement), effective as of September 3, 2010 (the Effective Date), is by and between Asklepios Biopharmaceutical, Inc., an entity organized and existing under the laws of the State of North Carolina, with its registered office located at 45 N. Chatham Parkway, Chapel Hill, NC 27517 (the AskBio), and Amsterdam Molecular Therapeutics (AMI) B.V., with offices located at Meibergdreef 61, 1100 DA Amsterdam, The Netherlands (AMT). AMT and AskBio may be hereinafter referred to individually as Party and jointly as Parties.

Applied Genetic Technologies Corp – Non-Exclusive License Agreement With Sublicensing Terms (January 10th, 2014)

This Agreement is made effective the 19th day of January 2006 (hereinafter Effective Date) by and between The UAB Research Foundation (hereinafter UABRF), a nonstock, nonprofit Alabama corporation having an office at 701 20th Street South, Birmingham, AL 35294 USA and AGTC (hereinafter Licensee), a corporation organized and existing under the laws of Delaware and having a principal office at 12085 Research Drive, Alachua, Florida 32615.

Applied Genetic Technologies Corp – Standard Non-Exclusive License Agreement [**] Vectors License A10571 (January 10th, 2014)

This Agreement is made effective the 18th day of September, 2012, (the Effective Date) by and between the University of Florida Research Foundation, Inc. (hereinafter called UFRF), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation (hereinafter called Licensee), a small entity corporation organized and existing under the laws of Delaware;

uniQure B.V. – Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. NON-EXCLUSIVE LICENSE AGREEMENT (January 2nd, 2014)

This License Agreement (the Agreement), effective as of September 3, 2010 (the Effective Date), is by and between Asklepios Biopharmaceutical, Inc., an entity organized and existing under the laws of the State of North Carolina, with its registered office located at 45 N. Chatham Parkway, Chapel Hill, NC 27517 (the AskBio), and Amsterdam Molecular Therapeutics (AMI) B.V., with offices located at Meibergdreef 61, 1100 DA Amsterdam, The Netherlands (AMT). AMT and AskBio may be hereinafter referred to individually as Party and jointly as Parties.

Non-Exclusive License Agreement (November 12th, 2013)

This Agreement is made effective as of the date of the last to sign party on page 15 ("Effective Date"), by and between the Wisconsin Alumni Research Foundation ("WARF"), a nonprofit Wisconsin corporation, and Asterias Biotherapeutics Incorporated ("Asterias"), a corporation organized and existing under the laws of Delaware, and its Affiliates who agree to sign on and be bound by the terms and obligations of this Agreement (collectively, "Licensee"). To the extent any Affiliate exercises any rights granted to Licensee hereunder, Asterias is liable to WARF for the duties and obligations of any such Affiliate, and any act or omission of an Affiliate that constitutes a breach of this Agreement shall be deemed to be a breach by Asterias.

Asterias Biotherapeutics, Inc. – Non-Exclusive License Agreement (November 12th, 2013)

This Agreement is made effective as of the date of the last to sign party on page 15 ("Effective Date"), by and between the Wisconsin Alumni Research Foundation ("WARF"), a nonprofit Wisconsin corporation, and Asterias Biotherapeutics Incorporated ("Asterias"), a corporation organized and existing under the laws of Delaware, and its Affiliates who agree to sign on and be bound by the terms and obligations of this Agreement (collectively, "Licensee"). To the extent any Affiliate exercises any rights granted to Licensee hereunder, Asterias is liable to WARF for the duties and obligations of any such Affiliate, and any act or omission of an Affiliate that constitutes a breach of this Agreement shall be deemed to be a breach by Asterias.

uniQure B.V. – Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. NON-EXCLUSIVE LICENSE AGREEMENT (November 8th, 2013)

This License Agreement (the Agreement), effective as of September 3, 2010 (the Effective Date), is by and between Asklepios Biopharmaceutical, Inc., an entity organized and existing under the laws of the State of North Carolina, with its registered office located at 45 N. Chatham Parkway, Chapel Hill, NC 27517 (the AskBio), and Amsterdam Molecular Therapeutics (AMI) B.V., with offices located at Meibergdreef 61, 1100 DA Amsterdam, The Netherlands (AMT). AMT and AskBio may be hereinafter referred to individually as Party and jointly as Parties.

Applied Genetic Technologies Corp – Non-Exclusive License Agreement With Sublicensing Terms (November 4th, 2013)

This Agreement is made effective the 19th day of January 2006 (hereinafter Effective Date) by and between The UAB Research Foundation (hereinafter UABRF), a nonstock, nonprofit Alabama corporation having an office at 701 20th Street South, Birmingham, AL 35294 USA and AGTC (hereinafter Licensee), a corporation organized and existing under the laws of Delaware and having a principal office at 12085 Research Drive, Alachua, Florida 32615.